| Cardiac Surgery |
1 |
1 |
| Surgery |
0 |
0.91 |
| Coronary Artery Bypass Graft (CABG) |
0 |
1 |
| Acute Coronary Syndrome |
0 |
0.44 |
| Hemorrhage |
0 |
0.24 |
| Clinical Guidelines |
0 |
0.18 |
| Arrhythmia |
0 |
0.17 |
| Heart |
0 |
0.15 |
| Platelet Reactivity |
0 |
0.13 |
| Platelet Count |
0 |
0.9 |
| Perioperative Care |
0 |
0.09 |
| Blood Transfusion |
0 |
0.07 |
| Blood |
0 |
0.06 |
| Clinician Health and Well-Being |
0 |
0.06 |
| Europe |
0 |
0.06 |
| Ischemia |
0 |
0.06 |
| Medical Life |
0 |
0.06 |
| Pharmacodynamics |
0 |
0.06 |
| Tube Thoracostomy |
0 |
0.04 |
| Ventricular Tachycardia |
0 |
0.04 |
| Antiplatelet Agent |
0 |
1 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.03 |
| Artery |
0 |
0.03 |
| Canada |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| HIV Infection |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Infarction |
0 |
0.03 |
| Myocardial Infarction (MI) |
0 |
0.03 |
| New York |
0 |
0.03 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.03 |
| Plasma |
0 |
0.03 |
| Tachycardia |
0 |
0.03 |
| Thorax |
0 |
0.03 |
| Transfusion |
0 |
0.03 |